• 1. An air-stable organometallic polymer containing titanafluorene moieties obtained by the Sonogashira–Hagihara cross-coupling polycondensation?
  Alvin Tanudjaja,Shinsuke Inagi,Fusao Kitamura,Toshikazu Takata,Ikuyoshi Tomita Dalton Trans., 2021,50, 3037-3043
• 2. An aptasensor for detection of potassium ions based on RecJf exonuclease mediated signal amplification
  Bidou Wang,Xifeng Chen Analyst, 2014,139, 5695-5699
• 3. An alumina stabilized graphene oxide wrapped SnO2 hollow sphere LIB anode with improved lithium storage?
  Xiang Liu,Qian Sun,A. B. Djuri?i?,Maohai Xie,Baohu Dai,Jinyao Tang,Charles Surya,Changzhong Liao,Kaimin Shih RSC Adv., 2015,5, 100783-100789
• 4. An atom-economical protocol for direct conversion of Baylis–Hillman alcohols to β-chloro aldehydes in water?
  Raktani Bikshapathi,Sai Prathima Parvathaneni,Vaidya Jayathirtha Rao Green Chem., 2017,19, 4446-4450
• 5. An antioxidative galactomannan extracted from Chinese Sesbania cannabina enhances immune activation of macrophage cells?
  Chongyang Zhu,Xiaojia Bian,Xin Jia,Ning Tang,Yongqiang Cheng Food Funct., 2020,11, 10635-10644

6-Fluoroimidazo[1,2-a]pyridine-2-carboxylic acid (CAS 367900-94-5): A Versatile Building Block in Medicinal Chemistry

The 6-Fluoroimidazo[1,2-a]pyridine-2-carboxylic acid (CAS 367900-94-5) represents an important heterocyclic compound that has gained significant attention in pharmaceutical research and drug discovery. As a fluorinated imidazopyridine derivative, this compound serves as a valuable scaffold for the development of novel therapeutic agents, particularly in the fields of oncology, neurology, and infectious diseases.

Recent trends in medicinal chemistry have shown growing interest in imidazo[1,2-a]pyridine derivatives, with researchers actively exploring their potential as kinase inhibitors and GPCR modulators. The presence of both fluoro substitution and carboxylic acid functionality in this molecule makes it particularly attractive for structure-activity relationship studies and molecular optimization.

The 6-fluoroimidazopyridine core structure offers several advantages in drug design, including improved metabolic stability and enhanced binding affinity to biological targets. Many pharmaceutical companies are currently investigating similar compounds as potential treatments for conditions ranging from inflammatory disorders to certain types of cancer, making 6-Fluoroimidazo[1,2-a]pyridine-2-carboxylic acid a compound of significant commercial interest.

From a synthetic chemistry perspective, the imidazo[1,2-a]pyridine-2-carboxylic acid scaffold provides multiple sites for structural modification, allowing medicinal chemists to fine-tune pharmacological properties. The fluoro group at position 6 often contributes to increased membrane permeability and can influence the compound's electronic distribution, potentially leading to improved target engagement.

In analytical applications, 6-Fluoroimidazo[1,2-a]pyridine-2-carboxylic acid serves as a valuable reference standard and intermediate. Its unique spectral properties (particularly the characteristic fluorine NMR signal) make it useful for method development in HPLC and LC-MS analyses of related compounds.

The growing demand for fluorinated pharmaceutical intermediates has positioned CAS 367900-94-5 as an important compound in the fine chemicals market. With increasing research into targeted therapies and personalized medicine, the applications of this fluoro-substituted heterocycle continue to expand across multiple therapeutic areas.

Quality control of 6-Fluoroimidazo[1,2-a]pyridine-2-carboxylic acid typically involves rigorous purity assessment using techniques such as reverse-phase HPLC, mass spectrometry, and elemental analysis. The compound's stability under various storage conditions has been well-characterized, making it suitable for long-term research applications.

Recent patent literature reveals numerous applications of imidazo[1,2-a]pyridine derivatives in drug development, with several candidates containing the 6-fluoro substitution pattern advancing to clinical trials. This underscores the importance of CAS 367900-94-5 as a key intermediate in modern medicinal chemistry.

From a regulatory perspective, 6-Fluoroimidazo[1,2-a]pyridine-2-carboxylic acid is classified as a research chemical with no known significant hazards when handled properly. However, as with all fine chemicals, appropriate laboratory safety protocols should be followed during its use.

The commercial availability of 6-Fluoroimidazo[1,2-a]pyridine-2-carboxylic acid from multiple suppliers has increased in recent years, reflecting its growing importance in drug discovery programs. Pricing and availability typically depend on purity grade and quantity required, with custom synthesis options available for specialized research needs.

Looking ahead, the fluoroimidazopyridine structural motif is expected to remain relevant in pharmaceutical research, particularly as scientists explore new approaches to target protein-protein interactions and allosteric binding sites. The versatility of CAS 367900-94-5 as a synthetic intermediate ensures its continued utility across multiple areas of chemical biology and medicinal chemistry.

For researchers working with 6-Fluoroimidazo[1,2-a]pyridine-2-carboxylic acid, proper characterization using spectroscopic methods (including 1H, 13C, and 19F NMR) is essential to confirm identity and purity. The compound's solubility profile in various organic solvents and aqueous buffers has been well-documented in the literature.

In conclusion, 6-Fluoroimidazo[1,2-a]pyridine-2-carboxylic acid (CAS 367900-94-5) represents a valuable tool for medicinal chemists and pharmaceutical researchers. Its unique structural features and growing applications in drug discovery make it an important compound in the development of next-generation therapeutic agents across multiple disease areas.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)